Preview Mode Links will not work in preview mode

This Week in Cardiology

Aug 5, 2022

Hyperkalemia in heart failure, CV health in America, primary prevention ICDs, and a debate about posters at medical meetings are the topics discussed by John Mandrola, MD in this week’s podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I. Hyperkalemia in Heart Failure

- DIAMOND: Adding Patiromer Helps Optimize HF Meds, Foils Hyperkalemia

- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

- Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial

- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

- Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

II. CV Health in America

- ‘Staggering’ CVD Rise Projected in US, Especially in Minorities

- Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates

III. Primary Prevention ICDs in Modern Era

- Do ICDs Still ‘Work’ in Primary Prevention Given Today’s Recommended HF Meds?

- Guideline-Directed Medical Therapy and the Risk of Death in Primary Prevention Defibrillator Recipients

- Declining Risk of Sudden Death in Heart Failure

- Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

IV. Medical Meetings and Posters

- As Digital Posters Take Over, Traditionalists Push Back

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact